The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China

The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China

Qiang Shi,1 Shanlian Hu,2 Wesley E Furnback,3 Gregory F Guzauskas,3 Jiejing Shen,1 Bruce CM Wang3 1Lilly Suzhou Pharmaceutical Company, Ltd., Shanghai, People’s Republic of China; 2Shanghai Health Development Research Center, Shanghai, People’s Republic of China; 3Elysia Group, L...

Full description

Bibliographic Details
Main Authors: Shi Q, Hu S, Furnback WE, Guzauskas GF, Shen J, Wang BCM
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Non-small cell lung cancer
pemetrexed
patient assistance program
cost-utility analysis
China
Online Access:https://www.dovepress.com/the-cost-effectiveness-of-a-nsclc-patient-assistance-program-for-pemet-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/the-cost-effectiveness-of-a-nsclc-patient-assistance-program-for-pemet-peer-reviewed-article-CEOR

Similar Items